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Abstract
The objective was to study the effect of colpocleisis on pelvic support, symptoms, and quality of
life and report-associated morbidity and postoperative satisfaction. Women undergoing
colpocleisis for treatment of pelvic organ prolapse (POP) were recruited at six centers. Baseline
measures included physical examination, responses to the Pelvic Floor Distress Inventory, and
Pelvic Floor Impact Questionnaire. Three and 12 months after surgery we repeated baseline
measures. Of 152 patients with mean age 79 (±6) years, 132 (87%) completed 1 year follow-up.
Three and 12 months after surgery, 90/110 (82%) and 75/103 (73%) patients following up had
POP stage ≤1. All pelvic symptom scores and related bother significantly improved at 3 and 12
months, and 125 (95%) patients said they were either ‘very satisfied’ or ‘satisfied’ with the
outcome of their surgery. Colpocleisis was effective in resolving prolapse and pelvic symptoms
and was associated with high patient satisfaction.
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Introduction
By the year 2030, adults over 65 years of age will account for approximately 20% of the US
population [1], and an estimated 80% of those have at least one chronic medical condition
[2]. Since the prevalence of pelvic organ prolapse increases with age, gynecologists will be
required to care for an increasing number of older women seeking treatment for prolapse. In
older women who do not seek to maintain vaginal coital function, colpocleisis offers high
anatomic success rates [3]. Potential benefits compared to a reconstructive approach include
decreased operative time, blood loss, and recuperative time. Few studies have systematically
assessed the impact of colpocleisis on bladder and bowel symptoms using validated
questionnaires, especially over a clinically significant time period. Lacking this information,
clinicians are somewhat limited in their ability to fully counsel patients considering
colpocleisis for prolapse.
Our objectives were to determine the effect of colpocleisis on pelvic organ support, pelvic
symptoms, quality of life, and patient satisfaction, to describe the morbidity associated with
colpocleisis, to report patients’ assessment of sexual function and body image, and to
describe outcomes with and without concomitant incontinence surgery during clinical care
of patients undergoing colpocleisis.
Materials and methods
This cohort study enrolled patients planning to undergo colpocleisis and prospectively
followed them for 1 year after surgery. The study was performed at six sites of the National
Institute Health-funded Pelvic Floor Disorders Network. Each site obtained Institutional
Review Board approval, and all participants provided informed consent to participate.
Patients were eligible to participate in the study if they had decided to undergo colpocleisis
for advanced pelvic organ prolapse (pelvic organ prolapse quantification (POP-Q) stage III–
IV) and were able to comprehend and complete study forms and procedures.
At baseline, we recorded demographic measures, severity of prolapse as assessed using the
POP-Q system [4], postvoid residual urine volume measured by catheterization within 10
min of spontaneous void, and results of any preoperative objective testing for stress
incontinence. We neither standardized nor required preoperative testing for incontinence as
there was no data with which to base a recommendation of this type of preoperative clinical
testing. Similarly, we did not dictate management of any incontinence that was present.
When performed, acceptable forms of objective testing included standing cough stress test
with 300 mL instilled into the bladder, or multichannel urodynamic testing performed
according to each site’s standard protocol, with the prolapse reduced using ring forceps in
either case. We did not prescribe preoperative uterine evaluation when the surgical plan was
to leave the uterus in situ. Postoperative catheter management was determined by local
practices.
Study coordinators administered the following symptom and quality of life questionnaires in
person: Short Form-36 (SF-36) generic health-related quality of life questionnaire, Pelvic
Floor Distress Inventory (PFDI; including the Urinary Distress Inventory (UDI), Pelvic
Organ Prolapse Distress Inventory (POPDI) and Colorectal Anal Distress Inventory
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(CRADI)), Pelvic Floor Impact Questionnaire (PFIQ; including the Urinary Impact
Questionnaire (UIQ), the Pelvic Organ Prolapse Impact Questionnaire (POPIQ), and the
Colorectal Anal Impact Questionnaire (CRAIQ)), and a nonvalidated Body Image and
Satisfaction Questionnaire (see “Appendix”). The Short Portable Mental Status Examination
was administered at baseline to subjects aged 75 and older and to younger subjects who
appeared to have cognitive dysfunction during the interview; subjects with moderate to
severe intellectual dysfunction were to be excluded.
Colpocleisis and any additional procedures were performed according to surgeon preference.
The surgeon reported the type of colpocleisis performed, concomitant procedure(s)
performed including levator plication and/or perineorrhaphy, operating time, intraoperative
blood loss, and complications. Surgeons all preserved the anterior vaginal epithelium caudad
to the urethrovesical junction, leaving the distal 3 to 4 cm of the vagina patent. Total
colpocleisis was defined as removal of all vaginal epithelium cephalad to the urethrovesical
junction to the level of the vaginal cuff, both anteriorly and posteriorly. Partial colpocleisis
was defined as partial removal of the vaginal epithelium cephalad to the urethrovesical
junction anteriorly and posteriorly creating a longitudinal vaginal septum with bilateral
vaginal epithelium tunnels (e.g., LeFort colpocleisis).
We assessed vaginal topography 3 months and 1 year after surgery, including measurement
of total vaginal length (TVL), length of genital hiatus (GH), and perineal body (PB) while
straining. The total vaginal length was measured in the midline. Additionally, we recorded
the position of the most dependent point of the vaginal apex, anterior and posterior vagina
with respect to the leading skin edge of the vaginal introitus while straining, and staged this
based on the POPQ staging system [4]. Voiding status was recorded as either voiding
without difficulty, needing intermittent catheterization, or needing indwelling catheter.
Three months and 1 year after surgery, the SF-36, PFDI, and PFIQ were readministered
along with questions relating to a global assessment of satisfaction and of body image (see
“Appendix”). If subjects were unable to attend any postoperative clinic visit, study
questionnaire measures were collected by telephone. In the event that surgery was necessary
for recurrent prolapse, stress incontinence, or urinary retention, all postoperative measures
were obtained before reoperation or retreatment.
Stress incontinence symptoms were considered present if the participant responded “yes” to
any of three items in the “Stress” UDI subscale (leak with cough, sneeze, or laugh; leak with
exercise; leak with bend over or lift). Urge urinary symptoms were considered present if a
“yes” response was given to any of five items in the “Irritative” UDI subscale (urgency, urge
incontinence, frequency, nocturia, and enuresis). Symptoms were considered bothersome if
the subject chose “moderately” or “quite a bit” of bother.
To test whether PFDI and PFIQ subscales improved after surgery, we used two-sample
paired signed rank tests. McNemar's test was used to compare proportions of subjects with
incontinence symptoms before and after surgery.
Results
A total of 152 patients were recruited, whose demographic information is summarized in
Tables 1 and 2. After enrollment, no subject was excluded due to cognitive impairment.
Patients were predominantly Caucasian (92%), with age range 65–94 years. Partial
colpocleisis was performed in 88 (58%) and total colpocleisis in 64 (42%) patients.
Additional procedures performed at the time of colpocleisis included: hysterectomy (8%),
levator myorrhaphy (68%), and perineorrhaphy (96%). Seventy-one (47%) patients
underwent concomitant incontinence procedures: polypropylene midurethral sling (n=55),
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xenograft suburethral sling (n=2), suburethral plication (n=13), and periurethral collagen
injection (n=1).
The mean (±standard deviation (SD)) blood loss for the entire cohort was 119±97 mL and
the operative time was 112±51 min. The estimated blood loss in the total colpocleisis group
was significantly greater than in the partial colpocleisis group, 149 (±127) mL vs. 90 (±56)
mL, respectively (p=0.002), even after excluding patients who underwent concurrent
hysterectomy. Operative time in the total colpocleisis group was significantly longer than in
the partial colpocleisis group (121±41 vs. 94±47 min; p=0.0011). Intraoperative
complications were uncommon, with one patient each having cystotomy, ureteric kinking,
and urethral injury during the surgery. There were no reported rectal injuries. Mean hospital
stay was 1.6±0.7 days, and mean duration of catheterization was 1.4±0.9 days.
As detailed in Table 3, adverse events were commonly reported during the year following
surgery. Urogenital adverse events were most common, the majority representing urinary
tract infections. Serious adverse events requiring prolonged hospitalization or subsequent
surgery included two patients who were diagnosed with cancer during or after their index
hospitalization. One patient had endometrial cancer diagnosed from the endometrial
curettings obtained at the time of colpocleisis and subsequently underwent total abdominal
hysterectomy and staging with final diagnosis of stage IC grade I papillary endometrial
adenocarcinoma. Another had a noninvasive low-grade transitional cell bladder cancer
diagnosed during cystoscopy at the time of colpocleisis. Five months after colpocleisis, one
patient died of sepsis and congestive heart failure apparently unrelated to the surgical
experience. There was no difference in serious adverse events between the total and partial
colpocleisis groups.
One hundred ten and 103 patients had objective POP-Q assessment 3 and 12 months after
surgery, respectively. Those who did not have objective POP-Q assessment were similar at
baseline to those who did have objective assessment. One hundred and seven (97%) patients
at 3 months and 96 (93%) at 12 months had POP stage 2 or better (Table 4) with 90 (82%) at
3 months and 75 (73%) having POP stage 0 or 1. POP outcomes were similar in patients
with and without concomitant levator myorrhaphy and when those undergoing total
colpocleisis were compared to those undergoing partial colpocleisis. As expected, the
median postoperative TVL and GH measurements decreased and PB measurements
increased (p<0.0001). Also indicated in Table 4, stress incontinence symptoms were present
in almost half of the patients 1 year after surgery but were bothersome in only 14%.
Bothersome urge incontinence symptoms were present in 15% of patients 1 year after
surgery. All PFDI and PFIQ subscale scores improved after surgery (see Table 5) with
improvements attained by 3 months and maintained until 12 months after surgery
(p<0.0001).
Before surgery, 75% (105/140) of subjects had “any” complaint of stress urinary
incontinence (SUI) where 54% of subjects (75/139) had complaints of “bothersome” SUI
(Table 4). Preoperative objective stress testing was performed in 141 (92%) patients, with
objective evidence of stress urinary incontinence demonstrated in 40 of 70 (57%) with
bothersome stress incontinence and in 28 of 58 (48%) without bothersome stress
incontinence symptoms.
The prevalence of new onset vs. persistent bothersome stress incontinence symptoms after
surgery are presented in Tables 6. Bothersome stress incontinence symptoms 1 year after
surgery were reported by 13% (8/62) of women who had an incontinence procedure and
14% (8/57) of women who did not have an incontinence procedure.
FitzGerald et al. Page 4













No patients had surgery for postoperative voiding difficulty, but one patient required use of
an indwelling catheter because of urinary retention at 3 months after surgery. Four patients
underwent further treatment for prolapse or incontinence during the year after colpocleisis:
one underwent repeat colpocleisis and three underwent suburethral sling procedure for stress
incontinence.
One year after surgery, looking back on their decision to have vaginal closure for treatment
of their prolapse, 78 (59%) patients said they were ‘very satisfied’, 47 (35%) were
‘satisfied’, five (4%) ‘neither satisfied nor dissatisfied’, one (1%) ‘dissatisfied’, and one
(1%) ‘very dissatisfied’. At 1 year, 87 (66%) said they were ‘very satisfied with the outcome
of their vaginal surgery’, 37 (28%) were ‘satisfied’, five (4%) were ‘neither satisfied nor
dissatisfied’, one (1%) were ‘dissatisfied’, and two (2%) were ‘very dissatisfied’. One year
after surgery, only two (2%) of women indicated that compared to before their surgery; they
thought their body now looked ‘worse’ while 49 (37%) indicated their body looked ‘the
same’ and 80 (61%) indicated their body looked ‘better.’ Similarly, only three (2%) noted a
worsening in the way their boy now felt with 121 (92%) indicating their bodies felt ‘better.’
Finally, just two (3%) stated that since the surgery, their sexual function was ‘worse’, with
69 (87%) indicating it was the same and eight (10%) indicated sexual function was ‘better’.
Discussion
This multisite prospective cohort study utilized validated subjective and objective outcome
measures to describe outcomes in a cohort of older women choosing colpocleisis for
treatment of prolapse. In line with other case series, we found that colpocleisis has a high
prolapse repair success rate at 1 year. We found little change in anatomic outcome between
the 3 month and 1 year postoperative visits, and just one subject underwent a repeat
colpocleisis. This is consistent with clinical experience and with a recent literature review
[3] that reported success rates between 91% and 100% with follow-up intervals ranging
from 2 weeks to 15 years. Paralleling the anatomic outcome, there was also a significant
improvement in prolapse symptoms and life impact as measured by condition-specific
symptom and life impact scales completed 3 months and 1 year after surgery.
We found that intraoperative procedure-specific complications were uncommon but that
general postsurgical adverse events were relatively common in this group of older women.
Since reporting of complications in women undergoing colpocleisis has been variable in
quality, our ability to compare our experience with other cohorts is limited but broadly
appears to be similar. Complications related to gastrointestinal, pulmonary, and
cardiovascular organ systems were most common during the initial hospitalization and
occurred at levels similar to those previously reported [3]. Importantly, we found that
urogenital events, the majority of which were urinary tract infections, occurred in 45% of
patients between discharge and 3 months after surgery and in 38% of subjects between 3
months and 1 year after surgery. Since urosepsis can be an important source of morbidity in
the older woman, we believe this result raises but does not answer the question of whether
prophylactic antibiotics should be considered for a time after urogenital surgery in similar
older patients.
Lower urinary tract symptoms and their life impact markedly improved by the 3 month
assessment, an improvement that was maintained at the 1 year follow-up. Only 14% of
patients expressed bother with stress incontinence symptoms at 1 year, compared to 54% at
baseline. Similarly, only 15% described bother with urge symptoms at 1 year, compared to
41% at baseline. These outcomes are in agreement with the significant decrease in UDI
subscales (stress, irritative, and obstructive) previously reported in a retrospective cohort of
54 subjects [5]. Importantly, we were able to show improvement in both stress and urge
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urinary incontinence symptoms both in patients who did and did not have a concomitant
incontinence procedure performed. We did not dictate the form of preoperative urinary tract
evaluation and did not prescribe treatment when urinary incontinence was present.
Therefore, our results do not add significantly to what is known about management of the
lower urinary tract at the time of colpocleisis but do suggest that a randomized trial may be
helpful in helping to define definitive management in this population of women undergoing
obliterative surgery. In our cohort, similar rates of postoperative bothersome SUI occurred at
1 year in those who did and did not undergo concomitant incontinence procedures (13% and
14%, respectively); furthermore, rates of this outcome appeared similar in women who did
and did not undergo incontinence surgery when preoperative bothersome SUI was present
(17% and 21%, respectively) and absent (8% and 7%, respectively). Importantly, new-onset
troublesome SUI was not common, whether or not an incontinence procedure was
performed, being present at 1 year in just 4% of patients who had an incontinence procedure
and in 3% of patients who did not. In contrast to what might be clinically expected in this
older cohort, no patients required urethrolysis or sling excision for persistent voiding
difficulty after surgery, although three patients required a subsequent sling surgery. While
these results may be useful in counseling women planning colpocleisis about benefits and
potential risks associated with concomitant incontinence surgery, we are unable to make
firm conclusions about our findings, since the decision to perform an incontinence surgery
was not standardized in this observational study.
We also explored issues related to sexual function, body image, and satisfaction after
colpocleisis. There has been some concern that a procedure which significantly alters female
anatomy and ability to have vaginal intercourse may adversely affect body image, cause
regret about loss of vaginal function, and ultimately cause patient dissatisfaction [6, 7].
Barber et al. recently compared a cohort of older women undergoing obliterative procedures
to a cohort undergoing reconstructive vaginal surgery for prolapse and found that women
choosing an obliterative approach had similar improvements in quality of life without an
increase in depression or alteration in body image [6]. Similarly, we found that 1 year after
surgery, 94% of patients were satisfied or very satisfied with their decision to have vaginal
closure for management of their prolapse, the majority were similarly satisfied with the
outcome of their surgery, and deterioration in sexual function was seldom reported.
Limitations of this study include the lack of a comparator group of similar women
undergoing reconstructive surgery or nonsurgical treatment for prolapse. We also did not
include geriatric-specific measures of functional status that may have been particularly
revealing about perioperative effects of prolapse surgery. Lastly (as above), since this was
an observational study, we did not standardize the objective preoperative and postoperative
bladder evaluation and the decision whether to perform a concomitant incontinence
procedure and we cannot make firm conclusions or recommendations regarding the
management of this clinically difficult problem at this time.
As the number of older women seeking care for prolapse continues to increase, it is
imperative that we are able to adequately counsel these patients with respect to risks and
benefits of this surgical approach. Further studies addressing the best approach to the
management of both overt and potential stress incontinence in the setting of colpocleisis are
needed.
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Body image and satisfaction
We were interested in learning about how women feel after prolapse surgery. There are no
right or wrong answers. We are just interested in learning about how you feel after your
surgery. I will start with the first question:
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Table 1




BMI Body mass index
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Table 2
Clinical and demographic characteristics of patients at baseline (n=152)
n (%)
Race
  Black 12 (8%)  
  White 140 (92%)
Hispanic ethnicity 3 (2%)  
Marital status
  Married or living as married 65 (43%)
  Other 87 (57%)
Education
  Less than high school 32 (21%)
  Completed high school or equivalent 68 (45%)
  Some college or higher 52 (34%)
Prior surgery for incontinence 20 (13%)
Prior hysterectomy 92 (60%)
Prior surgery for prolapse 31 (20%)
POP-Q stage
  Stage III 91 (62%)
  Stage IV 55 (38%)
POP-Q Pelvic organ prolapse quantification
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Table 3
Adverse events during the first postoperative year classified by event type or organ system affected; unless










Urogenital 5 69 (68 patients) 58
Pulmonary 11b 2 0
GI 14 5c 2
Skin/wound 2 9 (7 patients) 1
Infection 5 4 0
Cardiovasculara 6 1 4 (3 patients)
Neurologic 2 1 4
Neoplasm 3 1 1
Endocrine and allergy 0 4 0
Musculoskeletal 0 1 7
Death 0 0 1
Other (hyponatremia) 1 0 0
a
Includes emergency room visits for chest pain, regardless of eventual attribution
b
Includes one patient who developed pulmonary edema requiring intubation and ventilation
c
Includes one patient who developed new-onset rectal prolapse after colpocleisis and underwent subsequent surgical repair
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Table 4
POP-Q measurements and urinary incontinence symptoms at baseline, 3 and 12 months after surgery




Anatomic measures (data available for146
patients at baseline, 110 at 3 months, and 103
12 months after surgery)
Most distal vaginal point (leading
edge)
  ≤1 cm inside hymen 0 (0%) 90/110 (82%) 75/103 (73%)
  ≤1 cm beyond hymen 0 (0%) 107/110 (97%) 96/103 (93%)
  >1 cm beyond hymen 146/146 (100%) 3/110 (3%) 7/103 (7%)
TVL (cm) 9 (8, 10) 3 (3, 4) 3 (2.5, 4)
GH (cm) 6 (4, 7) 2 (1.5, 3) 2 (1.5, 3)
PB (cm) 3 (2, 4) 4 (4, 5.5) 4 (4, 5)




105/140 (75%) 63/136 (46%) 62/131 (47%)
Bother with stress incontinence
present
75/139 (54%) 26/135 (19%) 18/130 (14%)
UUI/OAB symptoms present 91/140 (65%) 43/136 (32%) 50/131 (38%)
Bother with UUI/OAB present 58/140 (41%) 16/136 (12%) 20/131 (15%)
Data presented as n (%) or median (interquartile range)
POP-Q Pelvic organ prolapse quantification, TVL total vaginal length, GH genital hiatus, PB perineal body
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Table 5
Questionnaire scores related to generic health-related quality of life, pelvic symptoms, and life impact at





3 months after surgery
141
12 months after surgery
132
SF36 physical 42±9  43.2±16.3a 44.3±15.7c
SF36 mental 51±10 51.7±18.6 55.5±19.0a
PFDI—POPDI 113±61 25.35±31.5b 26.03±30.65b
PFDI—UDI 97±56 26.19±29.02b 26.68±32.32b
PFDI—CRADI 71±63 37.17±48.17b 41.24±50.75b
PFIQ—POPIQ 45±64 6.36±20.62b 6.98±22.19b
PFIQ—UIQ 71±67 23.90±36.65b 23.65±39.85b
PFIQ—CRAIQ 34±58 12.81±32.94b 16.15±44.44b
Data presented as mean±SD. SF36 physical—range 0–100, higher score implies better quality of life. SF36 mental—range 0–100, higher score
implies better quality of life. OPDI subscale of the PFDI—range 0–300, lower scores indicate less bother. UDI subscale of the PFDI—range 0–300,
lower scores indicate less bother. CRADI subscale of the PFDI—range 0–400, lower scores indicate less bother. POPIQ subscale of the PFIQ—
range 0–400, lower scores indicate less life impact. UIQ subscale of the PFIQ—range 0–400, lower scores indicate less life impact. CRAIQ
subscale of the PFIQ—range 0–400, lower scores indicate less life impact
PFDI Pelvic Floor Distress Inventory, POPDI Pelvic Organ Prolapse Distress Inventory, UDI Urinary Distress Inventory, CRADI Colorectal Anal
Distress Inventory, PFIQ Pelvic Floor Impact Questionnaire, POPIQ Pelvic Organ Prolapse Impact Questionnaire, UIQ Urinary Impact
Questionnaire, CRAIQ Colorectal Anal Impact Questionnaire, SF36 physical physical component of the SF36, SF36 mental mental component of
the SF36
a
SF36 subscore significantly improved compared to baseline (p<0.005)
b
Three-month and 1-year subscores significantly improved compared to baseline (p<0.0001)
c
SF36 subscore significantly improved compared to baseline (p=0.015)
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